Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen-Yi Yang

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Sensors (Basel, Switzerland)|January 2, 2020
Sensor Classification Using Convolutional Neural Network by Encoding Multivariate Time Series as Two-Dimensional Colored ImagesChao-Lung Yang, Zhi-Xuan Chen, Chen-Yi Yang
Cardiovascular Diabetology|January 20, 2021
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic reviewChen-Yi Yang, Ying-Ren Chen, Huang-Tz Ou, et al.
Oncology Reports|January 16, 2014
siRNA-mediated knockdown of hTDE2 retards cell cycle progression through transcriptional activation of p21Wei-Hua Ren, Chen-Yi Yang, Xian-Mei Yang, et al.
British Journal of Clinical Pharmacology|November 30, 2019
Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 yearsTsung-Ying Lee, Shihchen Kuo, Chen-Yi Yang, et al.
Cardiovascular Diabetology|June 15, 2020
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort studyChun-Ting Yang, Chen-Yi Yang, Huang-Tz Ou, et al.
Scientific Reports|January 8, 2022
Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studiesChen-Yi Yang, Shihchen Kuo, Edward Chia-Cheng Lai, et al.
Scientific Reports|February 19, 2021
A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetesChun-Ting Yang, Kuan-Ying Li, Chen-Yi Yang, et al.
Cardiovascular Diabetology|July 8, 2020
Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetesChen-Yi Yang, Pei-Fang Su, Jo-Ying Hung, et al.
Diabetologia|November 16, 2017
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal studyChieh-Hsiang Lu, Chen-Yi Yang, Chung-Yi Li, et al.
International Journal of Cardiology|January 8, 2017
Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011Huang-Tz Ou, Kai-Cheng Chang, Chung-Yi Li, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Sensors (Basel, Switzerland)|January 2, 2020
Sensor Classification Using Convolutional Neural Network by Encoding Multivariate Time Series as Two-Dimensional Colored ImagesChao-Lung Yang, Zhi-Xuan Chen, Chen-Yi Yang
Cardiovascular Diabetology|January 20, 2021
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic reviewChen-Yi Yang, Ying-Ren Chen, Huang-Tz Ou, et al.
Oncology Reports|January 16, 2014
siRNA-mediated knockdown of hTDE2 retards cell cycle progression through transcriptional activation of p21Wei-Hua Ren, Chen-Yi Yang, Xian-Mei Yang, et al.
British Journal of Clinical Pharmacology|November 30, 2019
Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 yearsTsung-Ying Lee, Shihchen Kuo, Chen-Yi Yang, et al.
Cardiovascular Diabetology|June 15, 2020
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort studyChun-Ting Yang, Chen-Yi Yang, Huang-Tz Ou, et al.
Scientific Reports|January 8, 2022
Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studiesChen-Yi Yang, Shihchen Kuo, Edward Chia-Cheng Lai, et al.
Scientific Reports|February 19, 2021
A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetesChun-Ting Yang, Kuan-Ying Li, Chen-Yi Yang, et al.
Cardiovascular Diabetology|July 8, 2020
Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetesChen-Yi Yang, Pei-Fang Su, Jo-Ying Hung, et al.
Diabetologia|November 16, 2017
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal studyChieh-Hsiang Lu, Chen-Yi Yang, Chung-Yi Li, et al.
International Journal of Cardiology|January 8, 2017
Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011Huang-Tz Ou, Kai-Cheng Chang, Chung-Yi Li, et al.
Pageof 5